Related Experiment Video
Updated: Jun 11, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Endoscopic Sleeve Gastroplasty After Solid Organ Transplantation: First Reported Case Worldwide in a Kidney
Ehab Abufarhaneh1,2, Ayed Alqahtani3, Barham Abu Dayyeh4
1Organ Transplant Center of Excellence, King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia.
None:
Obesity adversely affects graft and cardiovascular outcomes in kidney transplant recipients, with limited effective therapies. Endoscopic sleeve gastroplasty (ESG) is established for obesity but not well studied post-transplant. We report ESG in a 33-year-old kidney transplant recipient with class III obesity. A structured search (PubMed, Embase, Scopus; January 2025) found no prior cases. ESG was completed without complications. At 6 months, meaningful weight loss and metabolic improvement occurred, with stable graft function. Semen parameters improved, without proven causality. ESG appears feasible and well tolerated in a selected patient. Safety cannot be established. Larger studies are needed.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
